University of Cincinnati researchers just dropped some seriously hopeful news for blood cancer patients at a major hematology conference. They’re testing a new drug that’s working for people with chronic lymphocytic leukemia who didn’t respond to other treatments—83% saw results and side effects were chill. There’s also a new targeted therapy for rare blood diseases and a coaching program that’s helping veterans better manage their care. Plus, they’re even tackling cognitive issues in sickle cell disease. Major science vibes! #Health #BodyHealth #BloodCancer